Skip to main content
SpringerLink
Log in

Maternal Drug Use and Infant Congenital Malformations

  • Book
  • © 2019

Overview

Authors:
  1. Bengt Källén

    1. Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Features the unique combination of detailed literature evaluation and presentation of new data

  • Focuses on research experiences since the 1960s within the field

  • Includes tables and diagrams that present details of the findings, which can be useful for researchers in the field

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (37 chapters)

  1. Front Matter

    Pages i-xviii
    Download chapter PDF

  2. Background

    • Bengt Källén
    Pages 1-13

  3. Maternal Use of Antacids or Drugs for Gastroesophageal Reflux Diagnosis (GERD) or Stomach Ulcer and Infant Congenital Malformations

    • Bengt Källén
    Pages 15-22

  4. Maternal Use of Drugs for Intestinal Problems, Except Intestinal Inflammations, and Infant Congenital Malformations

    • Bengt Källén
    Pages 23-31

  5. Maternal Use of Drugs for Inflammatory Intestinal Disease and Infant Congenital Malformations

    • Bengt Källén
    Pages 33-39

  6. Maternal Use of Anti-Obesity Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 41-45

  7. Maternal Use of Insulin or Oral Hypoglycemic Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 47-53

  8. Maternal Use of Vitamins and Infant Congenital Malformation

    • Bengt Källén
    Pages 55-64

  9. Maternal Use of Anticoagulants or Hemostatic Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 65-72

  10. Maternal Use of Drugs for Cardiovascular Diseases and Infant Congenital Malformations

    • Bengt Källén
    Pages 73-93

  11. Maternal Use of Dermatologic Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 95-106

  12. Maternal Use of Prolactin Inhibitors or Sex Hormones and Infant Congenital Malformations

    • Bengt Källén
    Pages 107-122

  13. Maternal Use of Drugs for Thyroid Disease and Infant Congenital Malformations

    • Bengt Källén
    Pages 123-131

  14. Maternal Systemic Use of Corticosteroids and Infant Congenital Malformations

    • Bengt Källén
    Pages 133-139

  15. Maternal Use of Hypophyseal or Hypothalamic Hormones and Infant Congenital Malformations

    • Bengt Källén
    Pages 141-143

  16. Maternal Use of Antibacterial or Antifungal Drugs for Systemic Use and Infant Congenital Malformations

    • Bengt Källén
    Pages 145-179

  17. Maternal Use of Antiviral Drugs, Immune Globulins, or Vaccines and Infant Congenital Malformations

    • Bengt Källén
    Pages 181-195

  18. Maternal Use of Cytostatic/Cytotoxic Drugs or Endocrine Drugs for Malignancy and Infant Congenital Malformations

    • Bengt Källén
    Pages 197-201

  19. Maternal Use of Immunostimulating or Immunosuppressive Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 203-212

  20. Maternal Use of NSAID Drugs and Infant Congenital Malformations

    • Bengt Källén
    Pages 213-221
Back to top

Keywords

About this book

This book is the combination of the literature on maternal drug use and birth defects with a set of new data on most types of drugs. 

In this book, for each group of drugs the relevant scientific literature on drug teratogenicity is presented, with consideration of possible sources of error and also what the findings may mean from a practical point of view. The book also adds data from the Swedish health registers for 1996-2013 based on more than 1.7 million early-pregnancy midwife interviews. 

Maternal Drug Use and Infant Congenital Malformations will find an engaged audience among people working within the field, and will be of interest to healthcare providers, especially obstetricians and other clinicians who treat women of childbearing age.


Reviews


Authors and Affiliations

  • Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    Bengt Källén

About the author

Bengt Källén, MD, PhD, is professor emeritus of the Tornblad Institute at Lund University in Lund, Sweden. Dr. Källén has been professor in embryology since 1965, was head of the Tornblad Institute from 1965-2017, and served as a consultant at the National Board of Health and Welfare in Stockholm from 1964-2015. He has published about 400 scientific articles, many of which concern drug use during pregnancy, and a number of books.

Bibliographic Information

  • Book Title: Maternal Drug Use and Infant Congenital Malformations

  • Authors: Bengt Källén

  • DOI: https://doi.org/10.1007/978-3-030-17898-7

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2019

  • Hardcover ISBN: 978-3-030-17897-0Published: 11 July 2019

  • Softcover ISBN: 978-3-030-17900-7Published: 15 August 2020

  • eBook ISBN: 978-3-030-17898-7Published: 29 June 2019

  • Edition Number: 1

  • Number of Pages: XVIII, 425

  • Number of Illustrations: 16 illustrations in colour

  • Topics: Obstetrics/Perinatology/Midwifery, Drug Safety and Pharmacovigilance, Epidemiology, Maternal and Child Health

Publish with us

Policies and ethics

Back to top

Search

Navigation